Insiders · Profile

Hague Richard

Chief Commercial Officer at Anika Therapeutics. Filing since 30 Nov 2017. CIK 0001656557

Company
Date
Role
Action
Shares
Amount
Of holding
30 Nov 2017
Chief Commercial Officer
Sold, plan not stated
5,250
$286.02K
18.2%
1 decision on file.